Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects

被引:38
作者
De Riccardis, L. [1 ]
Buccolieri, A. [1 ]
Muci, M. [1 ]
Pitotti, E. [2 ]
De Robertis, F. [3 ]
Trianni, G. [3 ]
Manno, D. [4 ]
Maffia, M. [1 ,2 ]
机构
[1] Univ Salento, Dept Biol & Environm Sci & Technol, Via Monteroni, Lecce, Italy
[2] ASL Lecce, Giovanni Paolo Hosp 2, Lab Clin Prote, Lecce, Italy
[3] ASL Lecce, Vito Fazzi Hosp, Dept Neurol, Lecce, Italy
[4] Univ Salento, Dept Math & Phys Ennio De Giorgi, Lecce, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2018年 / 1864卷 / 05期
关键词
Multiple sclerosis; Copper; Ceruloplasmin; Serum; Cerebrospinal fluid; Oxidative stress; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; PROTEIN OXIDATION; SUPEROXIDE-DISMUTASE; FERROXIDASE ACTIVITY; WILSONS-DISEASE; BRAIN; ZINC; IRON;
D O I
10.1016/j.bbadis.2018.03.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although many studies have been carried out in order to understand the implication of copper (Cu) in the pathogenesis of multiple sclerosis (MS), the exact role that this metal plays in the disease is not still clear. Because of the lack of information in this subject, the present study compared the serum and cerebrospinal (CSF) levels of copper in MS patients in respect to a control group, matched for age and sex, finding a significant increase of metal concentrations, in both biological fluids of MS subjects. To confirm the possible impairment of Cu metabolism, we analyzed ceruloplasmin (Cp) level and activity, seeing as this protein is an established peripheral marker in diseases associated with Cu imbalance. By comparing these two parameters between control and MS subjects, we found an increase of Cp levels, associated with a decrease in Cp activity, in the second group. By analysing these data, free copper levels were calculated, significantly increased in serum of MS subjects; the increase in free copper could be one of the predisposing factors responsible for the Cu altered levels in CSF of MS patients. At the same time, this alteration could be attributable to the inability to incorporate Cu by Cp, probably due to the high oxidative environment found in serum of MS patients. Overall, all these copper alterations may play a role in MS pathogenesis.
引用
收藏
页码:1828 / 1838
页数:11
相关论文
共 50 条
  • [31] Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies (vol 24, pg 175, 2011)
    Ventriglia, Mariacarla
    Bucossi, Serena
    Panetta, Valentina
    Squitti, Rosanna
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (04) : 981 - 984
  • [32] Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study
    Yalachkov, Yavor
    Anschuetz, Victoria
    Maiworm, Michelle
    Jakob, Jasmin
    Schaller-Paule, Martin A.
    Schaefer, Jan Hendrik
    Reilaender, Annemarie
    Friedauer, Lucie
    Behrens, Marion
    Steffen, Falk
    Bittner, Stefan
    Foerch, Christian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 71
  • [33] Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy
    Mitosek-Szewczyk, Krystyna
    Gordon-Krajcer, Wanda
    Walendzik, Piotr
    Stelmasiak, Zbigniew
    FOLIA NEUROPATHOLOGICA, 2010, 48 (02) : 116 - 122
  • [34] Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
    Fialova, Lenka
    Bartos, Ales
    Svarcova, Jana
    Zimova, Denisa
    Kotoucova, Jolana
    Malbohan, Ivan
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 113 - 120
  • [35] Differential expression of ceruloplasmin isoforms in the cerebrospinal fluid of amyotrophic lateral sclerosis patients
    Conti, Antonio
    Iannaccone, Sandro
    Sferrazza, Barbara
    De Monte, Lucia
    Cappa, Stefano
    Franciotta, Diego
    Olivieri, Stefano
    Alessio, Massimo
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (12) : 1628 - 1637
  • [36] Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid
    Barbariga, Marco
    Curnis, Flavio
    Andolfo, Annapaola
    Zanardi, Alan
    Lazzaro, Massimo
    Conti, Antonio
    Magnani, Giuseppe
    Volonte, Maria Antonietta
    Ferrari, Laura
    Comi, Giancarlo
    Corti, Angelo
    Alessio, Massimo
    MOLECULAR NEURODEGENERATION, 2015, 10
  • [37] The Cerebrospinal Fluid in Multiple Sclerosis
    Deisenhammer, Florian
    Zetterberg, Henrik
    Fitzner, Brit
    Zettl, Uwe K.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [38] Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis
    Harris, Violaine K.
    Donelan, Nicola
    Yan, Qi Jiang
    Clark, Kristi
    Touray, Amir
    Rammal, Mustapha
    Sadiq, Saud A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 1462 - 1472
  • [39] Cerebrospinal fluid proteome profile in multiple sclerosis
    Lehmensiek, V.
    Suessmuth, S. D.
    Touscher, G.
    Brettschneider, J.
    Felk, S.
    Gillardon, F.
    Tumani, H.
    MULTIPLE SCLEROSIS, 2007, 13 (07): : 840 - 849
  • [40] Serum Copper and Ceruloplasmin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Kul, Muslum
    Kara, Mahmut
    Unal, Fatih
    Tuzun, Zeynep
    Akbiyik, Filiz
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 24 (02): : 139 - 145